p-fviii-101
p-fviii-101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Poseida Therapeutics, Inc. (PSTX) | Preclinical |
Get deeper analysis on p-fviii-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis